NCT05564572

Brief Summary

This randomized quality improvement study evaluates the routine assessment of patient-reported heath status, using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) among adult outpatients seen in heart failure clinic or seen in general cardiology clinic with a history of heart failure. Patients will be randomized 4:1 to KCCQ-12 assessment or usual care. Participants randomized to KCCQ-12 assessment will complete the KCCQ-12 at every heart failure clinic visit. Their results will be available to clinicians to assist with clinical management. Heath status surveys will not be integrated into clinical care for patients in the usual care arm. The primary objective is to evaluate the impact of routine assessment of patient-reported heath status on clinical processes of care. As the primary outcome, we will evaluate clinician inertia by measuring the clinician action rating (CAR) - an aggregate count of medication changes, referrals, and diagnostic tests. As secondary outcomes, we will measure individual components of the composite outcome, therapy rates, resource utilization, and patient experience.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for not_applicable heart-failure

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

September 7, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

October 3, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2023

Completed
Last Updated

October 3, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 1, 2022

Last Update Submit

September 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinician action rating

    Aggregate count of medication changes, referrals, and diagnostic tests ordered per clinic visit

    From date of randomization to study completion (up to 12 months)

Secondary Outcomes (18)

  • Medication Changes

    From date of randomization to study completion (up to 12 months)

  • Referrals

    From date of randomization to study completion (up to 12 months)

  • Diagnostic Tests

    From date of randomization to study completion (up to 12 months)

  • Percentage of Patients on Beta-blocker Therapy and Median Dose Among Patients with Reduced Ejection Fraction

    From date of randomization to study completion (up to 12 months)

  • Percentage of Patients on Renin-Angiotensin-Aldosterone System Inhibitors and Median Dose Among Patients with Reduced Ejection Fraction

    From date of randomization to study completion (up to 12 months)

  • +13 more secondary outcomes

Study Arms (2)

Health Status Assessment

EXPERIMENTAL

Completion of a patient-reported health status assessment preceding each clinic visit. The health status assessment consists of the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) along with additional select questions. The results of the assessment will be available to clinicians in the electronic health record.

Other: Routine Health Status Assessment

Usual Care

NO INTERVENTION

Patients will not complete a patient-reported health status measures.

Interventions

Completion of a patient-reported health status assessment preceding each clinic visit. The health status assessment consists of the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) along with additional select questions. The results of the assessment will be available to clinicians in the electronic health record.

Health Status Assessment

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Seen in Stanford general cardiology clinic with a diagnosis of heart failure or cardiomyopathy or in heart failure clinic

You may not qualify if:

  • Enrolled in PRO-HF trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Hospital & Clinics

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor of Medicine

Study Record Dates

First Submitted

September 1, 2022

First Posted

October 3, 2022

Study Start

September 7, 2022

Primary Completion

September 7, 2023

Study Completion

December 7, 2023

Last Updated

October 3, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations